The association between alcohol consumption and bladder cancer risk has been insufficiently investigated in East Asian populations, who frequently have the inactive enzyme for metabolizing acetaldehyde. Given that acetaldehyde associated with alcohol consumption is assessed as a carcinogen, consideration of differences in acetaldehyde exposure would aid accuracy in assessing the bladder cancer risk associated with alcohol consumption. Here, we conducted a population-based cohort study in Japan to examine this association, including information on the flushing response as a surrogate marker of the capacity of acetaldehyde metabolism. Hazard ratios (HR) and 95% confidence intervals (CI) were estimated using multivariate Cox proportional hazard models. During follow up from 1990 through 2012 for the 95,915 subjects (45,649 men and 50,266 women, aged 40-69 years), 354 men and 110 women were newly diagnosed with bladder cancer. No significant association between alcohol consumption and bladder cancer risk was observed in the overall analysis. Among male flushers, HRs were 1.04 (95% CI 0.70-1.54), 1.67 (1.16-2.42), 1.02 (0.62-1.67) and 0.63 (0.33-1.20) for alcohol consumption of 1-150, 151-300, 301-450, >450 g/week of pure ethanol compared with non-drinkers and occasional drinkers, respectively, indicating an inverted U-shaped association between alcohol consumption and bladder cancer risk. In contrast, no significant association was identified among male non-flushers. The marginally significant interaction between alcohol consumption and the flushing response (p for interaction 5 0.083) may support our hypothesis that acetaldehyde derived from alcohol consumption is associated with bladder cancer risk. A prospective study considering polymorphisms of genes involved in acetaldehyde metabolism is warranted.
The association between alcohol consumption and bladder cancer risk has been insufficiently investigated in East Asian populations, who frequently have the inactive enzyme for metabolizing acetaldehyde. Given that acetaldehyde associated with alcohol consumption is assessed as a carcinogen, consideration of differences in acetaldehyde exposure would aid accuracy in assessing the bladder cancer risk associated with alcohol consumption. Here, we conducted a population-based cohort study in Japan to examine this association, including information on the flushing response as a surrogate marker of the capacity of acetaldehyde metabolism. Hazard ratios (HR) and 95% confidence intervals (CI) were estimated using multivariate Cox proportional hazard models. During follow up from 1990 through 2012 for the 95,915 subjects (45,649 men and 50,266 women, aged 40-69 years), 354 men and 110 women were newly diagnosed with bladder cancer. No significant association between alcohol consumption and bladder cancer risk was observed in the overall analysis. Among male flushers, HRs were 1.04 (95% CI 0.70-1.54), 1.67 (1.16-2.42), 1.02 (0.62-1.67) and 0.63 (0.33-1.20) for alcohol consumption of 1-150, 151-300, 301-450, >450 g/week of pure ethanol compared with non-drinkers and occasional drinkers, respectively, indicating an inverted U-shaped association between alcohol consumption and bladder cancer risk. In contrast, no significant association was identified among male non-flushers. The marginally significant interaction between alcohol consumption and the flushing response (p for interaction 5 0.083) may support our hypothesis that acetaldehyde derived from alcohol consumption is associated with bladder cancer risk. A prospective study considering polymorphisms of genes involved in acetaldehyde metabolism is warranted.
Age-standardized incidence rates of bladder cancer among men in Japan and East Asia were estimated to be 9.8 and 5.8 per 100,000, respectively, and those of mortality were 2.4 and 2.3 per 100,000, respectively.
1 Japanese men had the highest incidence rate of bladder cancer in East Asia. Several epidemiological studies have examined the association between alcohol drinking and bladder cancer risk, and a meta-analysis conducted in 2011 demonstrated no significant association. 2 Most studies included in that meta-analysis were performed in the United States and European countries, however, and only two studies were conducted in Asian countries, both in Japan. 2 To our knowledge, five case-control studies but no cohort studies have estimated odds ratios for bladder cancer risk associated with alcohol consumption in East Asian countries. [3] [4] [5] [6] [7] Of these case-control studies, a relatively large-scale study with 739 cases and 7,196 controls showed a statistically significant increased risk of bladder cancer among ever drinkers in a Japanese population. 7 Furthermore, odds ratios of ever drinkers compared with never drinkers in the remaining case-control studies ranged from 1.1 to 1.9, albeit without statistically significant results. [3] [4] [5] [6] These findings might indicate a positive association between alcohol consumption and bladder cancer risk in East Asian populations, contrary to the results in Western populations. Polymorphisms of genes encoding alcohol-metabolizing enzymes in East Asian populations are known to differ from those in Western populations, and these differences might account for the higher incidence of alcohol-related cancers such as oesophageal cancer in East Asian countries. 8 Given that carcinogenesis frequently occurs through the influence of environmental and genetic factors acting together, the impact of alcohol drinking in East Asian populations may differ from that in Western populations. A prospective study to examine the impact of alcohol consumption on bladder cancer risk in East Asian populations is therefore warranted. Acetaldehyde, a metabolite of ethanol, has been assessed by the International Agency for Research on Cancer (IARC) as a group I carcinogen. 9 Aldehyde dehydrogenase 2 (ALDH2) is a key enzyme in acetaldehyde metabolism and the ALDH2 polymorphism (rs671, Glu504Lys) is specific to East Asian populations. 10 Those with ALDH2 Lys alleles show significantly reduced enzymatic activity in acetaldehyde metabolism compared with ALDH2 Glu/Glu. 11, 12 We previously reported that ALDH2 rs671 modified the effect of alcohol consumption on bladder cancer risk in a Japanese population, suggesting an association between acetaldehyde derived from alcohol consumption and bladder cancer risk. 6 These findings suggest that evaluating differences in acetaldehyde exposure associated with alcohol consumption may help clarify the impact of alcohol drinking on bladder cancer risk in East Asian populations. Acetaldehyde accumulation is responsible for the facial flushing response to alcohol consumption as well as for its carcinogenic effect. 13 A recent meta-analysis showed that the flushing response was associated with oesophageal cancer risk even after adjustment for potential confounders, 14 suggesting the possibility that the flushing response can be used as a surrogate marker of acetaldehyde metabolism capacity in humans. We therefore hypothesized that analyses which included information on flushing response may improve accuracy in evaluating the association between acetaldehyde exposure related to alcohol consumption and bladder cancer risk. This association may be effectively examined in a Japanese population, because approximately half of Japanese have the inactive ALDH2 Lys allele associated with the flushing response.
6,15
Here, we conducted a population-based cohort study in Japan to investigate the association between alcohol consumption and bladder cancer risk, taking flushing response after alcohol consumption into consideration.
Material and Methods

Study population
The Japan Public Health Center-based Prospective Study (JPHC study) is a large-scale population-based cohort study. 16 The participants were defined as all registered Japanese inhabitants in 11 public health center (PHC) areas throughout Japan, and enrolled in 1990 for Cohort I (subject age range 40 to 59 years) and in 1993 for Cohort II (subject age range 40 to 69 years). All subjects in one PHC area (Tokyo) were excluded from the present analysis because incidence data were not available, and some in another PHC (Osaka) were also excluded because its study population had been defined differently. The study protocol was approved by the institutional review boards of the National Cancer Center, Tokyo, and Aichi Cancer Center, Nagoya, Japan.
Baseline survey and variables
A baseline survey was conducted in 1990 for Cohort I and in 1993-1994 for Cohort II, with a response rate of 81%. Lifestyle information, including alcohol consumption, flushing response after drinking alcohol and smoking habit, was collected using self-administered questionnaires completed by study participants at baseline. Data on alcohol drinking habit at baseline were obtained using a validated self-administered food frequency questionnaire. 17 The method used to assess and categorize alcohol consumption has been detailed elsewhere. 17 Briefly, alcohol consumption was assessed differently between Cohorts I and II. For Cohort I, subjects were classified into the following six categories by average frequency of alcohol consumption:
What's new? Many East Asians possess an inactive form of aldehyde dehydrogenase 2, the enzyme responsible for metabolizing acetaldehyde, a breakdown product of ethanol. Whether this diminished capacity for acetaldehyde metabolism affects bladder cancer risk associated with alcohol consumption remains unclear. In this population-based cohort study in Japan, stratified analyses by facial flushing response, reflecting the capacity for acetaldehyde metabolism, show that moderate drinking (151-300 grams pure ethanol/week) is associated with elevated bladder cancer risk among flushers. Risk was not increased for heavy drinks or non-flushers. The results suggest that acetaldehyde metabolized from alcohol influences bladder cancer development.
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<1 day/month, 1-3 days/month, 1-2 days/week, 3-4 days/ week, 5-6 days/week and everyday. Subjects who consumed alcohol at least once a week were also asked to provide information on the types of alcoholic beverage and the average amount of consumption. For subjects in Cohort II, drinking status was classified into never, former or current. Former and current drinkers were asked about the average frequency and amount of alcohol consumption, and types of alcoholic beverage. The amount of alcohol consumption was converted to grams of pure ethanol per week. Men in Cohort I and Cohort II were then categorized into the six groups of nondrinkers (<1 day/month in Cohort I and II or former drinkers in Cohort II), occasional drinkers (1-3 days/month) and four groups of regular drinkers (1-150, 151-300, 301-450, >450 g/week of ethanol). For women, the latter three groups of regular drinkers (151-300, 301-450, >450 g/week of ethanol) were combined owing to the limited number of regular drinkers. With respect to the flushing response, the questionnaire asked 'Do you currently experience facial flushing as soon as you drink alcohol?' with the answers of 'yes', 'occasionally', 'no' and 'not certain' in Cohort I and 'yes', 'no' and 'not certain' in Cohort II. We regarded the answer 'occasionally' in Cohort I as a positive flushing response in accordance with a previous report in the JPHC study. 18 Smoking status was classified into never, former or current. Cumulative exposure to cigarette smoking among former and current smokers was assessed as pack-years (PY), the number of packs of cigarettes smoked per day multiplied by the number of years of smoking. PY was categorized into 0, 1-19, 20-29, 30-39 or 40.
Follow-up
Subjects were followed from the baseline survey until December 31, 2012. Residence status and survival were confirmed annually using the residential registry of each area or, for those who had moved out of the study area, through the municipal office of the area they moved to. Data on cancer occurrence were collected through two sources, local major hospitals and population-based cancer registries. Death certificate information was used as a supplementary information source. The site and histology of each cancer were coded using the International Classification of Diseases for Oncology, third edition (ICD-O-3). We identified ICD-O-3 C67.0-67.9 as bladder cancer cases. The proportion of cases for which the only information came from a death certificate (death certificate only, DCO%) was 3.0% for bladder cancer cases, indicating that the quality of data collected was sufficiently high.
Statistical analysis
Subjects who had missing values for alcohol consumption (n 5 1,601) or a self-reported history of cancer at baseline (n 5 2,301) were excluded from the analysis, leaving 95,915 subjects (45,649 men and 50,266 women) for analysis.
Person-years of follow-up were counted from the date of completion of the baseline questionnaire until the date of bladder cancer diagnosis, migration out of the study area, death or the end of the study period (December 31, 2012), whichever occurred first. Persons lost to follow-up were censored on the last confirmed date of presence in the study area. We estimated hazard ratios (HR) and 95% confidence intervals (CI) using multivariate Cox proportional hazard models as a measure of the association between alcohol consumption and the risk of bladder cancer. The combination of non-drinkers and occasional drinkers was set as the reference group in the drinking category. HRs for alcohol consumption were calculated using two models: Model 1 (HR1) was adjusted for age at baseline (continuous variable) and study area (10 PHC areas), while Model 2 was further adjusted for cumulative exposure to cigarette smoking (PY category). We also conducted analyses excluding cases diagnosed early within three years after enrolment in each study and excluded the possibility of reverse causality. The proportional hazards assumption for all of the models was confirmed using Schoenfeld residual tests.
Tests for linear trends in the risk of bladder cancer were assessed by assigning ordinal variables in drinking categories as continuous terms. Tests for quadratic trends were also conducted by including quadratic terms in the linear trend models. Interaction analyses were conducted to examine whether the association between alcohol consumption and bladder cancer risk differed by the presence of the flushing response. Interaction was assessed using a model which included interaction terms for the combination of alcohol drinking and flushing response in the categories. All statistical analyses were performed with STATA statistical software version 13.1 (StataCorp LP, College Station, TX). All p values were two-sided, and p values < 0.05 were considered to indicate statistical significance.
Results
During an average 18.2 years of follow up, 464 bladder cancer cases (354 men and 110 women) were newly diagnosed. Basic characteristics of the study participants by alcohol drinking category are shown in Table 1 . At baseline, 23.2%, 9.2% and 67.7% of men were non-drinkers, occasional drinkers and regular drinkers, respectively. In contrast, most women (78.9%) were non-drinkers, which was a much higher proportion than men. The proportion of flushers in men decreased with increasing alcohol consumption, whereas that in women did not appear related to the amount of alcohol consumption. Non-occasional and occasional drinkers were more likely to be never smokers among women than men. The association between cigarette smoking and bladder cancer risk is shown in the Supporting Information Table. A dose-response relationship was clearly identified among men. Table 2 shows the association between alcohol consumption and bladder cancer risk. The proportion of regular drinkers among patients with bladder cancer was much higher among men than women. Among men, moderate drinkers (151-300 g/week) showed the highest HR after adjustment for smoking compared with non-drinkers and occasional drinkers, albeit without statistical significance (HR 1.30, 95% CI 0.97-1.73). Regular drinkers with alcohol consumption of 301-450 g/week and >450 g/week showed HRs of 1.09 (95% CI 0.78-1.54) and 1.06 (95% CI 0.73-1.53), respectively. Among women, the HRs were 1.16 (95% CI 0.61-2.20) and 0.50 (95% CI 0.07-3.68) in those with alcohol consumption of 1-150 g/week and >150 g/week, respectively. Further stratified analysis among female bladder cases was hampered by the small number of regular drinkers. The following analyses which considered the flushing response were therefore restricted to men.
Flushing response was not associated with increased bladder cancer risk among men [flushers vs. non-flushers, HR 1.13 (95% CI 0.89-1.43)]. As shown in Table 3 , moderate drinkers (151-300 g/week) with a flushing response had the 
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highest HR and statistically significantly increased risk of bladder cancer compared with non-drinkers and occasional drinkers (HR 1.67, 95% CI 1.16-2.42), indicating an inverted U-shaped association between alcohol consumption and bladder cancer risk (p for linear trend 5 0.774, p for quadratic trend 5 0.001) In contrast, no statistically significant association between alcohol drinking and bladder cancer risk was observed in men without the flushing response (p for linear trend5 0.133, p for quadratic trend 5 0.579). Furthermore, no significant interaction between alcohol drinking and flushing response in bladder cancer risk was observed among men. To remove confounding by cigarette smoking, the most important risk factor for bladder cancer, 19 we restricted the analyses to never smokers. Table 4 shows that the association between alcohol consumption and bladder cancer risk according to flushing response was consistent with the overall analysis, as shown in Table 3 . Moderate drinking (151-300 g/week) with the flushing response was associated with bladder cancer risk (HR 4.21, 95%CI 1.63-10.9), whereas moderate drinkers without the flushing response had no significant increase in risk (HR 0.94, 95% CI 0.21-4.27) among male never smokers. A marginally significant interaction between moderate drinking and flushing response was identified in male never smokers (p for interaction 5 0.083). A flow chart of number of patients among men in the present analysis is shown in Supporting Information Figure. 
Discussion
We investigated the association between alcohol consumption and bladder cancer risk stratified by facial flushing response Table 3 . Association between alcohol drinking and bladder cancer risk among men with or without the alcohol flushing response Assessed by assigning ordinal variables in drinking category as continuous terms (Non/occasional drinker, 1-150, 151-300, 301-450, >450 g/week). 4 Assessed by including quadratic terms in the linear trend models. Abbreviations: CI: confidence interval; HR: hazard ratio.
in a population-based cohort study in Japan. The results showed that moderate drinkers (151-300 g/week) had an increased risk of bladder cancer compared with non-drinkers and occasional drinkers among men with the flushing response, but that heavy drinkers (>300 g/week) did not. In contrast, no significant association between alcohol consumption and bladder cancer risk was seen among male nonflushers. This lack of significant association is compatible with the results of a previous meta-analysis. 2 A flushing response seemed to be an effect modifier in bladder cancer risk associated with alcohol consumption, implying that acetaldehyde derived from alcohol consumption is involved in the development of bladder cancer. Acetaldehyde exposure has been shown to result in DNA damage, and the IARC assesses acetaldehyde associated with the consumption of alcoholic beverages as a group I carcinogen in humans. 9 In particular, acetaldehyde converted from ethanol is excreted through the urinary tract, 20 and the urothelium of the bladder is exposed to acetaldehyde in the urine. These findings may provide a plausible explanation for an increased risk of bladder cancer associated with acetaldehyde accumulation in urine.
On the basis of the hypothesis that acetaldehyde exposure plays an important role in the development of bladder cancer, those with a flushing response are assumed to be at higher risk of alcohol-associated bladder cancer than those without a flushing response. If all of the flushers in the present study had the inactive ALDH2 Lys alleles, one may expect that their risk of bladder cancer would increase with increasing alcohol consumption. In contrast, our results showed an inverted U-shaped association between the amount of alcohol consumption and bladder cancer risk among flushers, with the highest risk in the group consuming 151-300 g/week.
The inverted U-shaped association between alcohol consumption and bladder cancer risk among flushers may be explained by misclassification between self-reported flushing response and ALDH2 genotype. Our previous data from a general population in the same areas as the present study showed that 49% of flushers carried ALDH2 Glu/Glu. 18, 21 Oze et al. also reported similar findings, indicating that approximately half of heavy drinkers with a flushing response carried ALDH2 Glu/Glu, although 86% of never to highmoderate drinkers (corresponding to moderate drinkers in the present study) with the flushing response carried ALDH2 Lys alleles in another Japanese population. 22 These previous findings suggest that most moderate drinkers with a flushing response have ALDH2 Lys alleles, but that heavy drinkers with a flushing response include a considerable number of ALDH2 Glu/Glu carriers. As an interesting addition, our previous case-control study showed that those with the ALDH2 Lys alleles had a higher risk of bladder cancer with increasing alcohol consumption, whereas those with ALDH2 Glu/Glu had no increase in risk even if they drank heavily. 6 This finding suggests that the inclusion of those with ALDH2 Glu/Glu may attenuate the bladder cancer risk associated with heavy drinking among those with ALDH2 Lys alleles. Taken together, these findings suggest that heavy drinkers (>300 g/week), who are more likely to have ALDH2 Glu/Glu, may have no increased risk of bladder cancer compared with moderate drinkers (151-300 g/week), of whom ALDH2 Lys allele carriers account for a large proportion. Previous studies have pointed out the possibility of residual confounding by cigarette smoking even when alcoholassociated bladder cancer risk is estimated after adjustment for cigarette smoking. 2 To address this issue, we conducted subgroup analyses restricted to never smokers. Results showed that never smokers showed consistent findings with the overall analyses. This may reinforce our results that moderate drinking is associated with bladder cancer risk among flushers independently of tobacco use. This subgroup analysis, however, leads to the inevitable problem of loss of statistical power due to small sample size. Larger studies providing statistical power are therefore highly warranted.
To our knowledge, this is the first cohort study to examine the association of alcohol consumption with bladder cancer risk in an East Asian population. A further strength of our study is that analyses were stratified by flushing response, which is considered to reflect the individual's capacity to metabolize acetaldehyde. Our findings may therefore support the hypothesis that acetaldehyde is involved in the pathogenesis of bladder cancer.
The present study has several limitations. First, lifestyle characteristics of subjects were only available at baseline. Lifestyle may have changed after baseline assessment, which would lead to under-or over-estimation of alcohol-associated bladder cancer risk. Second, the questionnaire of Cohort I unfortunately failed to discriminate lifetime never drinkers and former drinkers, who might have stopped drinking due to health problems, and we cannot deny the possibility that subjects in the non-drinking category had consumed more alcohol in their lifetime than those in the occasional drinking category. To accommodate these conditions, we set the combination of non-drinkers and occasional drinkers as the reference group. Although this limitation might have led to underestimation of the association between alcohol drinking and bladder cancer risk, a significant association was in fact observed. Third, information on socioeconomic status and occupational carcinogen exposure was lacking. These variables may be associated with alcohol drinking habit as well as bladder cancer risk, 19 and we cannot rule out the possibility of confounding by these variables. Fourth, just in case the amount of acetaldehyde naturally included in alcoholic beverages is associated with acetaldehyde concentration in urine, types of alcoholic beverages consumed may bias our findings. Alcoholic beverages were reported to include acetaldehyde and the amount of acetaldehyde considerably varied by types of alcoholic beverages. 23, 24 However, acetaldehyde in alcoholic beverages was unlikely to influence acetaldehyde concentration in urine, given that blood acetaldehyde concentration was not significantly different by types of alcoholic beverages. 25 Thus, the impact of differences in acetaldehyde between types of alcoholic beverages on our findings may be small. Finally, a degree of misclassification regarding selfreported flushing response may be present. As shown above, we discussed the possibility that acetaldehyde was involved in bladder cancer risk by assuming the distribution of subject ALDH2 genotypes based on earlier findings in Japan. 18, 22 If this assumption were incorrect, our estimate that most moderate drinkers had the inactive enzyme for acetaldehyde metabolism would likely be incorrect. To address this limitation, analyses which include data on ALDH2 polymorphisms in subjects are essential.
In conclusion, our data show that moderate alcohol drinking among men with a flushing response is associated with an increased risk of bladder cancer. Our findings may support the hypothesis that acetaldehyde derived from alcohol consumption plays an important role in the development of bladder cancer. A prospective study which considers the polymorphisms of genes encoding the enzymes involved in acetaldehyde metabolism (ALDH2) in an East Asian population to verify this hypothesis is warranted.
